← back to search

Pallavi Vedantam

Novartis (Switzerland) · CH
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Genetic factors in colorectal cancer, Colorectal Cancer Treatments and Studies, Colorectal Cancer Surgical Treatments, and Microfluidic and Bio-sensing Technologies.
h-index
11
citations
725
works
34
NIH funding
primary concept
Medicine
email

Recent publications

Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses
Cancer Cell 2022cited by 46position: middledoi
Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer
Clinical Cancer Research 2021cited by 86position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chaitanya Bandlamudi · University of Chicago1 papers (2022–2022)Ya-Hui Lin · Kettering University1 papers (2022–2022)Philip Wong · Memorial Sloan Kettering Cancer Center1 papers (2022–2022)Alexander Solovyov · Icahn School of Medicine at Mount Sinai1 papers (2022–2022)Eunise Chen · University of Alabama at Birmingham1 papers (2022–2022)N. Esther Babady · American Academy of Arts and Sciences1 papers (2022–2022)Yuval Elhanati · Cancer Research And Biostatistics1 papers (2022–2022)Sigrid Gouma · University of Pennsylvania1 papers (2022–2022)Justin Kim · Temple University1 papers (2022–2022)Scott E. Hensley · Parker Institute for Cancer Immunotherapy1 papers (2022–2022)Santosha A. Vardhana · Presbyterian Hospital1 papers (2022–2022)Olga Lyudovyk · Weill Cornell Medicine1 papers (2022–2022)Madeline A. Hwee · Memorial Sloan Kettering Cancer Center1 papers (2022–2022)Lakshmi V. Ramanathan · Vellore Institute of Technology University1 papers (2022–2022)Benjamin D. Greenbaum · Icahn School of Medicine at Mount Sinai1 papers (2022–2022)Melanie Douglas · Solent NHS Trust1 papers (2022–2022)Sawsan R. Boutemine · Lymphoma Research Foundation1 papers (2022–2022)Alexander C. Huang · PolyGene1 papers (2022–2022)David Qualls · Harvard University1 papers (2022–2022)